Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly(The University of Texas MD Anderson Cancer Center), Herbert Levine(The University of Texas MD Anderson Cancer Center), Jason A. Somarelli(Duke University), Maya U. Sheth(Duke Medical Center), Adrian Biddle(Queen Mary University of London), Sharmila A. Bapat(National Centre for Cell Science), Samir Hanash(University of Michigan), Annapoorni Rangarajan(Indian Institute of Science Bangalore), Andrew J. Armstrong(Duke Medical Center), S. C. Tripathi(The University of Texas MD Anderson Cancer Center)
Cited by 337
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
|The EMBO Journal|2001|855